EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut–Liver Axis Failure in Critical Alcohol‐Associated Liver Disease: From ICU Secondary Hits to Microbiome‐Targeted Therapy

Yuting Zhang iD, Yiyu Wang iD, Yong Yang, Hong Mei iD, Xinxin Liu, Yuanxiu He, Song Qin iD, Banghai Feng iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/3968719 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, online erschienen am 31.05.2026. Verfasst von Yuting Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou, China, zmchospital.com.cn. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Liver, Gastrointestinal Microbiome. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zunyi Science and Technology Bureau, China, Guizhou Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol‐associated liver disease (ALD) can progress to critical illness phenotypes requiring intensive care, including severe alcohol‐associated hepatitis, acute decompensation, and alcohol‐associated acute‐on‐chronic liver failure (ACLF). In these patients, short‐term outcomes are driven less by the burden of fibrosis alone than by systemic inflammation, immune dysfunction, infection, and multiorgan failure. At the core of this process is gut–liver axis failure, which links alcohol‐induced dysbiosis and intestinal barrier disruption to microbial translocation, hepatic innate immune activation, and systemic inflammatory amplification. In the intensive care unit (ICU), secondary hits such as broad‐spectrum antibiotics, acid suppression, parenteral nutrition, shock, sedatives or opioids, and mechanical ventilation may further exacerbate these mechanisms and disturb microbial ecology and barrier integrity. Microbiome‐targeted therapies (probiotics, postbiotics, and fecal microbiota transplantation) are biologically plausible. However, current evidence is mainly derived from non‐ICU or relatively stable ALD populations. Therefore, their use in critically ill patients requires strict safety boundaries, including severe barrier disruption, invasive devices, uncontrolled infections, and profound immune dysfunction. This narrative review synthesizes the pathophysiological continuum from gut barrier failure to systemic inflammation and multiorgan dysfunction in critical ALD, with particular emphasis on ICU‐specific secondary hits, safety‐aware microbiome modulation, and future phenotype‐informed precision strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Diseases, AlcoholicLiverGastrointestinal MicrobiomeHumansIntensive Care UnitsAnimalsIntestinal Barrier FunctionFecal Microbiota TransplantationDysbiosis

Stichwörter der Autor:innen

alcohol-associated liver diseasegut–liver axisintensive careintestinal barrier dysfunctionmicrobiome-targeted therapymultiple organ dysfunction

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou, China, zmchospital.com.cn.
  • Department of Critical Care Medicine, Kweichow Moutai Hospital, Renhuai, 564500, Guizhou, China.
  • Department of Anesthesia and Perioperative Care, UCSF School of Medicine, San Francisco, 94158, California, USA, ucsf.edu.
  • Department of Critical Care Medicine, Zunyi Hospital of Traditional Chinese Medicine, Zunyi, 563000, Guizhou, China.

ORCID-Profile: Yuting Zhang, Yiyu Wang, Hong Mei, Song Qin, Banghai Feng

Förderung

  • National Natural Science Foundation of China
  • Zunyi Science and Technology Bureau, China
  • Guizhou Administration of Traditional Chinese Medicine
  • Guizhou Provincial Health Commission
  • Kweichow Moutai Hospital Research Project
  • Traditional Chinese Medicine Hospital of Zunyi Medical and Pharmaceutical College

Zitieren

APA

Zhang, Y., Wang, Y., Yang, Y., Mei, H., Liu, X., He, Y., Qin, S., & Feng, B. (2026). Gut–Liver Axis Failure in Critical Alcohol‐Associated Liver Disease: From ICU Secondary Hits to Microbiome‐Targeted Therapy. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/3968719

Vancouver

Zhang Y, Wang Y, Yang Y, Mei H, Liu X, He Y, et al. Gut–Liver Axis Failure in Critical Alcohol‐Associated Liver Disease: From ICU Secondary Hits to Microbiome‐Targeted Therapy. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/3968719

BibTeX
@article{Zhang2026,
  author = {Zhang, Yuting and Wang, Yiyu and Yang, Yong and Mei, Hong and Liu, Xinxin and He, Yuanxiu and Qin, Song and Feng, Banghai},
  title = {Gut–Liver Axis Failure in Critical Alcohol‐Associated Liver Disease: From ICU Secondary Hits to Microbiome‐Targeted Therapy},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/3968719}
}
Kostenlos starten →